Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-54
SponsorWake Forest University Health Sciences
About this trial
Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.
Eligibility criteria
Qualifiers
Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
Age 40-54 years at the time of consent.
A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
Ability to read and understand the English and/or Spanish language.
Disqualifiers
Known diagnosis of lung cancer in the past 5 years.
Any known contraindication to having a low-dose CT Scan.
Known pregnancy.
Trial design
Treatments tested in this trial
- Mobile Low-dose Computed Tomography (LDCT) Screening
Treatment groups
1,160 Participants
are divided into 1 treatment groupSponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Leon Levine Foundation
Collaborator
Source ClinicalTrials.gov